Three-dimensional structure-activity relationship analysis between motilin and motilide using conformational analysis and a novel molecular superposing method

被引:0
|
作者
Gouda, H
Sunazuka, T
Omura, S
Hirono, S
机构
[1] Kitasato Univ, Sch Pharmaceut Sci, Minato Ku, Tokyo 1088641, Japan
[2] Kitasato Inst, Biol Funct Res Ctr, Minato Ku, Tokyo 1088642, Japan
关键词
motilide; motilin; agonist; pharmacophore; molecular dynamics; alignment;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Motilide an erythromycin derivative, has been shown to equal activity to that of motilin as an agonist at the motilin receptor. However, there is little information on the three-dimensional (3D) structure-activity relationship between these two molecules, largely because they have quite different structures. In this study, we applied a rational computational procedure consisting of conformational analysis and a novel superposing method to investigate the 3D structure-activity relationship between motilide and motilin. We propose common 3D structural features between these molecules, which may be important for their similar activity.
引用
收藏
页码:1835 / 1837
页数:3
相关论文
共 50 条
  • [1] Three-dimensional quantitative structure-activity, relationship modeling of γ-secretase inhibitors using molecular field analysis
    Sammi, Tarnvir
    Silalkari, Om
    Ravikumar, Muttineni
    CHEMICAL BIOLOGY & DRUG DESIGN, 2008, 71 (02) : 155 - 166
  • [2] Three-Dimensional Classification Structure-Activity Relationship Analysis Using Convolutional Neural Network
    Moriwaki, Hirotomo
    Tian, Yu-Shi
    Kawashita, Norihito
    Takagi, Tatsuya
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2019, 67 (05) : 426 - 432
  • [3] Three-dimensional quantitative structure-activity relationship analysis of the new potent sulfonylureas using comparative molecular similarity indices analysis
    Hou, TJ
    Li, ZM
    Li, Z
    Liu, J
    Xu, XJ
    JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2000, 40 (04): : 1002 - 1009
  • [4] Molecular design of a novel fungicide metconazole and three-dimensional quantitative structure-activity relationship
    Chuman, H
    Ito, A
    Saishoji, T
    Kumazawa, S
    JOURNAL OF PESTICIDE SCIENCE, 1998, 23 (03): : 330 - 335
  • [5] Molecular modelling studies of sirtuin 2 inhibitors using three-dimensional structure-activity relationship analysis and molecular dynamics simulations
    Chuang, Yu-Chung
    Chang, Ching-Hsun
    Lin, Jen-Tai
    Yang, Chia-Ning
    MOLECULAR BIOSYSTEMS, 2015, 11 (03) : 723 - 733
  • [6] Conformational analysis of rhazinilam and three-dimensional quantitative structure-activity relationships of rhazinilam analogues
    Morita, H
    Awang, K
    Hadi, AHA
    Takeya, K
    Itokawa, H
    Kobayashi, J
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (04) : 1045 - 1050
  • [7] Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysis
    Shim, JY
    Collantes, ER
    Welsh, WJ
    Subramaniam, B
    Howlett, AC
    Eissenstat, MA
    Ward, SJ
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (23) : 4521 - 4532
  • [8] Three-dimensional quantitative structure-activity relationship analysis of acyclic and cyclic chloronicotinyl insecticides
    Okazawa, A
    Akamatsu, M
    Nishiwaki, H
    Nakagawa, Y
    Miyagawa, H
    Nishimura, K
    Ueno, T
    PEST MANAGEMENT SCIENCE, 2000, 56 (06) : 509 - 515
  • [9] Three-dimensional quantitative structure-activity relationship of melatonin receptor ligands: A comparative molecular field analysis study
    Sicsic, S
    Serraz, I
    Andrieux, J
    Bremont, B
    MatheAllainmat, M
    Poncet, A
    Shen, S
    Langlois, M
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (05) : 739 - 748
  • [10] Three-dimensional quantitative structure-activity relationship analysis of ligand binding to human sequence antidigoxin monoclonal antibodies using comparative molecular field analysis
    Farr, CD
    Tabet, MR
    Ball, WJ
    Fishwild, DM
    Wang, X
    Nair, AC
    Welsh, WJ
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (15) : 3257 - 3270